Cornerstone Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Buy
2,851
+126
+5% +$129K 0.28% 59
2026
Q1
$2.51M Buy
2,725
+59
+2% +$59.8K 0.24% 67
2025
Q4
$2.86M Buy
2,666
+40
+2% +$38.2K 0.27% 61
2025
Q3
$2M Buy
2,626
+35
+1% +$26K 0.2% 69
2025
Q2
$2.02M Buy
2,591
+15
+0.6% +$11.7K 0.22% 64
2025
Q1
$2M Buy
2,576
+45
+2% +$37.4K 0.23% 64
2024
Q4
$2.14M Sell
2,531
-14
-0.6% -$11.6K 0.24% 63
2024
Q3
$2.25M Buy
2,545
+14
+0.6% +$12.6K 0.3% 60
2024
Q2
$2.29M Buy
2,531
+94
+4% +$75.2K 0.32% 56
2024
Q1
$1.9M Buy
2,437
+496
+26% +$353K 0.27% 61
2023
Q4
$1.13M Buy
1,941
+209
+12% +$122K 0.18% 75
2023
Q3
$931K Buy
1,732
+50
+3% +$25.8K 0.16% 84
2023
Q2
$789K Buy
1,682
+35
+2% +$14.7K 0.14% 97
2023
Q1
$566K Buy
1,647
+162
+11% +$54.6K 0.1% 122
2022
Q4
$543K Buy
1,485
+317
+27% +$112K 0.11% 121
2022
Q3
$378K Hold
1,168
0.08% 135
2022
Q2
$379K Sell
1,168
-1,556
-57% -$467K 0.09% 133
2022
Q1
$780K Buy
2,724
+738
+37% +$190K 0.12% 132
2021
Q4
$549K Sell
1,986
-985
-33% -$250K 0.08% 168
2021
Q3
$686K Hold
2,971
0.11% 143
2021
Q2
$681K Hold
2,971
0.11% 136
2021
Q1
$556K Buy
2,971
+1,100
+59% +$215K 0.11% 143
2020
Q4
$316K Sell
1,871
-84
-4% -$12.5K 0.06% 168
2020
Q3
$289K Hold
1,955
0.07% 153
2020
Q2
$321K Buy
1,955
+200
+11% +$30.7K 0.08% 137
2020
Q1
$243K Hold
1,755
0.07% 135
2019
Q4
$231K Buy
+1,755
New +$203K 0.05% 153

Other funds holding LLY

Cornerstone Advisory's LLY Position: Q2 2026 in Review

Cornerstone Advisory increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $129K and bringing the position to 2,851 shares worth $3.42M. The position accounts for 0.28% of the portfolio, ranked #59.

Cornerstone Advisory first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cornerstone Advisory held 2,851 shares of Eli Lilly worth $3.42M as of Q2 2026.
  • Cornerstone Advisory bought 126 Eli Lilly shares in Q2 2026, an estimated $129K.
  • Eli Lilly made up 0.28% of Cornerstone Advisory's portfolio in Q2 2026, its #59 holding.
  • Cornerstone Advisory first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.